BDBM277368 US10072025, Example 3-2::tert-butyl 4-[3-({4-[(2,2- dimethylmorpholin-4- yl)carbonyl]-3- methylphenyl}amino)-4- oxo-4,5-dihydro-1H- pyrazolo[4,3-c]pyridin-1- yl]-4-ethylpiperidine-1- carboxylate

SMILES CCC1(CCN(CC1)C(=O)OC(C)(C)C)n1nc(Nc2ccc(C(=O)N3CCOC(C)(C)C3)c(C)c2)c2c1cc[nH]c2=O

InChI Key InChIKey=FIBWQYKYPYQEGW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 277368   

TargetTyrosine-protein kinase JAK1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM277368(US10072025, Example 3-2 | tert-butyl 4-[3-({4-[(2,...)
Affinity DataIC50: 0.610nMT: 2°CAssay Description:The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2018
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM277368(US10072025, Example 3-2 | tert-butyl 4-[3-({4-[(2,...)
Affinity DataIC50: 0.75nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2018
Entry Details
US Patent